The Woodlands, TX, United States of America

Dongxia Xing

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dongxia Xing

Introduction

Dongxia Xing is a notable inventor based in The Woodlands, TX (US). He has made significant contributions to the field of immunology, particularly in the development of methods for inducing immunologic responses to tumors. With a total of 3 patents to his name, his work is paving the way for advancements in cancer treatment.

Latest Patents

Dongxia Xing's latest patents focus on innovative methods utilizing mature dendritic cells. These methods involve transfecting dendritic cells with nucleic acid compositions that encode tumor antigens, which are then loaded with corresponding tumor antigen compositions. This approach aims to enhance the immunologic response in patients suffering from tumors, showcasing his commitment to improving cancer therapies.

Career Highlights

Dongxia Xing is affiliated with the University of Texas System, where he continues to engage in groundbreaking research. His work has garnered attention for its potential to revolutionize cancer treatment through immunotherapy. His dedication to advancing medical science is evident in his innovative approaches and research methodologies.

Collaborations

Dongxia Xing collaborates with esteemed colleagues such as William K Decker and Elizabeth J Shpall. These partnerships enhance the research environment and contribute to the development of effective cancer treatment strategies.

Conclusion

In summary, Dongxia Xing is a prominent inventor whose work in immunology is making a significant impact on cancer treatment. His innovative patents and collaborations reflect his dedication to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…